Novo Nordisk AS (NONOF)
87.52
-0.33
(-0.38%)
USD |
OTCM |
Dec 24, 12:44
Novo Nordisk Market Cap: 388.73B for Dec. 24, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly and Co | 754.78B |
| Genmab AS | 12.99B |
| Ascendis Pharma AS | 8.293B |
| Galecto Inc | 6.401M |
Market Cap Related Metrics
| PE Ratio | 28.36 |
| PS Ratio | 9.935 |
| PEG Ratio | 1.008 |
| Price to Book Value | 21.53 |
| Price to Free Cash Flow | 39.79 |
| Price | 87.52 |
| Earnings Yield | 3.53% |
| PEGY Ratio | 0.9524 |
| Operating PE Ratio | 22.70 |
| Normalized PE Ratio | 28.36 |